Ixochymostatin, a trypsin inhibitor-like (TIL) protein from Ixodes scapularis, inhibits chymase and impairs vascular permeability
Almeida Martins, L.; Berger, M.; Kotal, J.; Lu, S.; Sousa-Paula, L. C.; Smith, B. J.; Zhang, Y.; Andersen, J. F.; Tirloni, L.
Show abstract
Ticks, as pool feeders, obtain a blood meal by lacerating small blood vessels and ingesting the blood that flows to the feeding site, which triggers various host-derived responses. However, ticks face the challenge of wound healing, a process involving hemostasis, inflammation, cell proliferation and migration, and remodeling, hindering blood acquisition. To overcome these obstacles, tick salivary glands produce a diverse array of bioactive molecules. Here, we characterize ixochymostatin, an Ixodes scapularis protein belonging to the trypsin inhibitor-like (TIL) family. It is expressed in multiple developmental stages and in tick salivary glands and acts as a slow and tight-binding inhibitor of chymase, cathepsin G, and chymotrypsin. Predictions for the tertiary structure complex between ixochymostatin and chymase suggest a direct interaction between the inhibitors reactive site loop and protease active sites. In vitro, ixochymostatin protects the endothelial cell barrier against chymase degrading action, decreasing cell permeability. In vivo, it reduces vascular permeability induced by chymase and compound 48/80, a mast cell degranulator agonist, in a mouse model. Additionally, ixochymostatin inhibits the chymase-dependent generation of vasoconstrictor peptides. Antibodies against ixochymostatin neutralize its inhibitory properties, with epitope mapping identifying potential neutralization regions. Ixochymostatin emerges as a novel tick protein modulating host responses against tick feeding, facilitating blood acquisition. HighlightsO_LIIxochymostatin is a newly described trypsin inhibitor-like (TIL) protein from Ixodes scapularis. C_LIO_LIIxochymostatin inhibits chymase and reduces vascular permeability. C_LIO_LIIxochymostatin inhibits chymase-dependent generation of vasoconstrictive peptides. C_LIO_LIAntibodies generated against ixochymostatin neutralize its inhibitory functions. C_LIO_LIPotential epitopes responsible for anti-ixochymostatin neutralization were mapped. C_LI
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV2 mutant-specific T cells and neutralizing antibodies after vaccination and up to 1 year after infection 94%
- Potential mechanisms of action of celastrol against rheumatoid arthritis: transcriptomic and proteomic analysis 94%
- Blocking IL-10 signaling with soluble IL-10 receptor restores specific lymphoproliferative response in dogs with leishmaniasis caused by Leishmania infantum 94%
Similar papers in this journal
- CLEC18A interacts with sulfated GAGs and controls clear cell renal cell carcinoma progression 94%
- Non-prime- and Prime-side Profiling of Pro-Pro Endopeptidase Specificity Using Synthetic Combinatorial Peptide Libraries and Mass Spectrometry 93%
- High throughput competitive fluorescence polarization assay reveals functionalredundancy in the S100 protein family 92%
Similar papers in this journal
- Assessment of a western blot signal for the Bcnt/Cfdp1, a tentative component of Srcap chromatin remodeling complex; trial to overcome off-target problems 92%
- Glucose regulates expression of pro-inflammatory genes IL-1β and IL-12 through a mechanism involving hexosamine biosynthesis pathway dependent regulation of α-E catenin in the RAW 264.7 macrophage cell line 91%
- SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.